Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-103) for the Prevention of Pregnancy in Women

NCT00996580 is registered in ClinicalTrials.gov with Teva Women's Health as lead sponsor.

NCT NCT00996580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00996580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-103) for the Prevention of Pregnancy in Women
Lead sponsor
Teva Women's Health
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
September 30, 2011
Enrollment
3,597 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy prevention